BBCZ Financials 07/15/2014 23:32:30 Bodisen Biote
Post# of 3
Bodisen Biotech, Inc.
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 8,056 7,685 6,595
Cost of Revenue 6,942 5,609 5,742
Gross Profit 1,114 2,076 853
Operating Expenses
Research and Development - - -
Sales, General and Admin. 5,588 4,337 4,997
Non-Recurring Items 9,057 - -
Other - - -
Operating Income (13,531) (2,261) (4,144)
Income From Continuing Operations
Add'l Income/Expense Items (2,754) 96 67
Earnings Before Interest and Tax (16,285) (2,165) (4,077)
Interest Expense 84 146 93
Earnings Before Tax (16,370) (2,310) (4,170)
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (16,370) (2,310) (4,170)
Non Recurring Events
Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (16,370) (2,310) (4,170)
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (16,370) (2,310) (4,170)